OBJECTIVES

1. Discussing how to strengthen clinical trials enterprise utilizing Artificial Intelligence (AI) to optimize clinical trial design and conduct.
2. Contributing to positioning KSA in the clinical trials global map by enhancing global partnership opportunities
3. Bridging the gap between site, sponsors, and other clinical trial stakeholders
4. Sharing and adopting strategies for developing successful clinical trials agreements and dudgeting.
5. Discussing the future of decentralized clinical trials (DCTs) using advanced technology
6. Sharing international experiences and best practices in building clinical trial enterprises and setting the stage for high quality data